NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









pixlbio

pixlbio

Private
UppsalaHealthcare & Life Scienceshttps://www.pixl.bio/

Last Round

Pre Seed

Jan 30, 2025

Total Funding Raised

$1.09M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

pixlbio is a biotechnology company that provides iPSC-derived human models and AI-powered phenomics for drug discovery and safety assessment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

iPSC-derived hepatocytesdrug discoverytoxicology researchinduced pluripotent stem cellsiPSCpreclinical researchphenotypic screeninghigh-content imagingcell paintingpredictive toxicologyorgan-on-a-chipin vitro modelsAI-driven phenomicscontract research organizationCROalternative to animal testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

pixlbio Comparables

Compare pixlbio with similar companies based on industry and business-model similarity.

pixlbio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tempo Bioscience, Inc.
82%
Axol Bioscience
80%
NEXEL Co., Ltd.
79%

pixlbio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJan 30, 2025
AcceleratorSep 12, 2024

Key People

Founding team and executive leadership

Ludovic Vallier

Founder - Chief Scientific Officer

Founding Team

Morgan Ekmefjord

Co-Founder And CTO

Founding Team

Christopher Trummer

CEO Co-Founder

Founding Team

pixlbio Investors

Notable investors and investment history

pixlbio investors
InvestorRounds
Nordic Science InvestmentsPre Seed
Almi Invest ABPre Seed
Länsförsäkringar UppsalaPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors grew 275% MoM, reaching 2.1K.

  • Nov 13, 2025

    Launched pixHep, an iPSC-derived hepatocyte model.

pixlbio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

pixlbio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about pixlbio's valuation, stock price, and market status.

Firmographic Details

HeadquartersUppsala
Employee Range20
Year Founded2021
Last FundingJan 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.